What Does NRx Pharmaceuticals' Recent $22.3 Million Offering Mean for Investors

Related Articles

What Does Hitek Global's Recent $8 Million Offering Mean for Investors

4 months ago

What Does BriaCell's Latest Offering Mean for Investors

4 months ago

What Does Getty Realty's $131 Million Stock Offering Mean for Investors

7 months ago

What Does EPRT's Latest Debt Offering Mean for Investors

4 months ago

Category

You may also like

Stock News•3 weeks ago

NRx Pharmaceuticals: Promising Ketamine Opportunity In Psychiatry

NRx Pharmaceuticals' KETAFREE ketamine opportunity could become a commercial business if FDA approval leads to a successful launch, with the bull case hinging on future commercialization.

NRXP

Share

Stock News•1 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q2 2026 Earnings Call Transcript

NRx Pharmaceuticals reported Q2 2026 results, with financial performance and operational updates detailed in the earnings call. The company highlighted progress on key programs, though specific figure...

NRXP

Share

Stock News•2 months ago

Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock

Dyne Therapeutics priced an upsized $375M public offering of 18.3M shares at $20.50 each, diluting existing holders to fund operations for its neuromuscular disease programs.

DYN

Share